Sharon Shacham

Insider Reports History

Location
Newton, MA
Signature
/s/ Adam D. Levy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sharon Shacham:

Company Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. Chief Scientific Officer Common Stock 958,131 $785,667 $0.8200 29 Mar 2022 Direct
Karyopharm Therapeutics Inc. Chief Scientific Officer Common Stock 713,757 $585,281 $0.8200 29 Mar 2022 By Spouse
Karyopharm Therapeutics Inc. Chief Scientific Officer Stock Option (right to buy) 90,000 29 Mar 2022 Direct
Acrivon Therapeutics, Inc. Director Stock Option (Right to Buy) 20,275 13 Jun 2025 Direct

Insider Reports Filed by Sharon Shacham

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRV Acrivon Therapeutics, Inc. 13 Jun 2025 1 $0 4 Director 17 Jun 2025, 17:54
ACRV Acrivon Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 17:27
ACRV Acrivon Therapeutics, Inc. 14 Nov 2022 1 $0 4 Director 16 Nov 2022, 18:28
ACRV Acrivon Therapeutics, Inc. 09 Nov 2022 0 $0 3 Director 09 Nov 2022, 19:30
KPTI Karyopharm Therapeutics Inc. 29 Mar 2022 2 $0 4 Chief Scientific Officer 31 Mar 2022, 16:17
KPTI Karyopharm Therapeutics Inc. 28 Feb 2022 4 -$127,477 4 Chief Scientific Officer 02 Mar 2022, 14:20
KPTI Karyopharm Therapeutics Inc. 17 Feb 2022 2 -$220,246 4 Chief Scientific Officer 22 Feb 2022, 15:15
KPTI Karyopharm Therapeutics Inc. 07 Feb 2022 2 -$132,851 4 Chief Scientific Officer 09 Feb 2022, 16:22